SCHEMBL6366642

SCHEMBL6366642

O=S(=O)(N[C@H](CO)c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
EEF2K O00418 3/20 0.54
MMP2 P08253 2/20 0.50
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.47
GBA1 P04062 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
MMP1 P03956 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP13 P45452 1/20 0.47
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
KMT2A Q03164 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287324 0.89 MEN1 (0.57) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL27639242 0.89 ALDH1A1 (0.52) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL1287456 0.89 MEN1 (0.57) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL8842173 0.89 KMT2A (0.58) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL15387943 0.89 MEN1 (0.57) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL3199799 0.89 ALDH1A1 (0.52) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL1287460 0.85 SLC1A3 (0.53) EEF2KSLC1A3SLC1A2SLC1A1TP53
SCHEMBL28404274 0.83 ATM (0.76) ALDH1A1ATML3MBTL1EEF2KKMT2A
SCHEMBL7207108 0.82 GBA1 (0.51) ALDH1A1ATML3MBTL1EEF2KMMP2
SCHEMBL5651951 0.80 EEF2K (0.59) ALDH1A1ATML3MBTL1EEF2KSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270902-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2012-10-25 US disclosed
US-8193389-B2 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2012-06-05 US disclosed
US-20050245573-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245573-A1 N-substituted benzene sulfonamides PSEN1, PSEN2, BCHE ALDH1A1 665/4885ATM 1881/4885L3MBTL1 2429/4885
US-20120270902-A1 N-substituted benzene sulfonamides PSEN1, PSEN2, BCHE ALDH1A1 665/4885ATM 1881/4885L3MBTL1 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.